COVID Vaccine: Johnson & Johnson Says Single Shot Vaccine Effective In Trials
Published
The New Jersey-based company said Friday the single-shot vaccine was 66% effective overall and 85% against the most serious symptoms.
Full ArticlePublished
The New Jersey-based company said Friday the single-shot vaccine was 66% effective overall and 85% against the most serious symptoms.
Full ArticleWatch VideoNew data has been released for a COVID vaccine candidate that would require only one dose.
According to..
The vaccine from Johnson & Johnson has been found to be safe. Meanwhile, the EU has authorized AstraZeneca's vaccine. Latest..